MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

NeoGenomics Inc

Geschlossen

6.24 -6.73

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

6.21

Max

6.71

Schlüsselkennzahlen

By Trading Economics

Einkommen

-11M

-26M

Verkäufe

-4M

168M

Gewinnspanne

-15.427

Angestellte

2,200

EBITDA

-10M

-6.3M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+59.97% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

29. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-359M

924M

Vorheriger Eröffnungskurs

12.97

Vorheriger Schlusskurs

6.24

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

NeoGenomics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

18. Juli 2025, 14:33 UTC

Wichtige Markttreiber

MEI Pharma Stock Surges on $100 Million Private Placement, Litecoin Treasury Strategy

17. Juli 2025, 21:14 UTC

Akquisitionen, Fusionen, Übernahmen

Basel Medical Group Puts $1 Billion Bitcoin Purchase on Hold

17. Juli 2025, 18:49 UTC

Akquisitionen, Fusionen, Übernahmen

Bitcoin Standard Treasury to Go Public Via SPAC Deal

14. Juli 2025, 17:06 UTC

Wichtige Markttreiber

Crypto Assets Rally Ahead of Possible U.S. Legislation

18. Juli 2025, 14:31 UTC

Market Talk

U.S. Regulation is Driving Crypto Demand -- Market Talk

18. Juli 2025, 14:18 UTC

Wichtige Markttreiber

MEI Pharma Stock Surges on $100M Private Placement, Litecoin Treasury Strategy

18. Juli 2025, 07:06 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18. Juli 2025, 07:06 UTC

Market Talk

Bitcoin Rises on Optimism Over U.S. Regulation -- Market Talk

17. Juli 2025, 21:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. Juli 2025, 21:45 UTC

Market Talk

Crypto Bills Welcomed by Venture Capital, Trade Group Says -- Market Talk

17. Juli 2025, 20:59 UTC

Akquisitionen, Fusionen, Übernahmen

Basel Medical Group Puts $1B Bitcoin Purchase on Hold

17. Juli 2025, 14:37 UTC

Market Talk

Ethereum Outperforms as Bitcoin Stays Stuck Below $120,000 -- Market Talk

17. Juli 2025, 13:06 UTC

Akquisitionen, Fusionen, Übernahmen

Cantor Equity Partners I, Upon Closing, Combined Company Expected to Trade Under Ticker Symbol BSTR >CEPO

17. Juli 2025, 13:06 UTC

Akquisitionen, Fusionen, Übernahmen

Bitcoin Standard Treasury to Go Public Through Business Combination With Cantor Equity Partners I

17. Juli 2025, 09:19 UTC

Market Talk

Bitcoin Falls, Stays at High Levels Amid Focus on U.S. Legislation -- Market Talk

17. Juli 2025, 09:19 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16. Juli 2025, 13:41 UTC

Akquisitionen, Fusionen, Übernahmen

This Crypto Stock Is Soaring. Peter Thiel Just Made a Big Bet. -- Barrons.com

16. Juli 2025, 11:16 UTC

Akquisitionen, Fusionen, Übernahmen

This Crypto Stock Soared 30%. Peter Thiel Just Made a Big Bet. -- Barrons.com

16. Juli 2025, 09:05 UTC

Market Talk

Bitcoin Turns Higher Again Ahead of Possible U.S. Legislation -- Market Talk

15. Juli 2025, 15:15 UTC

Market Talk

Sovereign Adoption of Bitcoin is Rising -- Market Talk

15. Juli 2025, 14:40 UTC

Market Talk

Global Equities Roundup: Market Talk

15. Juli 2025, 14:40 UTC

Market Talk

Stablecoins Aren't a Long-Term Store of Value -- Market Talk

15. Juli 2025, 14:05 UTC

Market Talk

Investors More Sensitive to Risk of Crypto Collapse -- Market Talk

15. Juli 2025, 13:20 UTC

Market Talk

Bitcoin's Recent Rally Could Extend Further -- Market Talk

15. Juli 2025, 13:20 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15. Juli 2025, 12:42 UTC

Market Talk

Global Equities Roundup: Market Talk

15. Juli 2025, 12:42 UTC

Market Talk

Widespread Bitcoin Adoption Is Still Some Way Off -- Market Talk

15. Juli 2025, 08:22 UTC

Market Talk

Bitcoin Hit by Profit-Taking After Surge to Record Highs -- Market Talk

14. Juli 2025, 15:54 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

14. Juli 2025, 15:54 UTC

Market Talk

'Crypto Week' Legislation Would Overhaul U.S. Crypto Policy -- Market Talk

Peer-Vergleich

Kursveränderung

NeoGenomics Inc Prognose

Kursziel

By TipRanks

59.97% Vorteil

12-Monats-Prognose

Durchschnitt 10.75 USD  59.97%

Hoch 12 USD

Tief 8.5 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für NeoGenomics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

10 ratings

6

Buy

4

Halten

0

Sell

Technischer Score

By Trading Central

7.7 / 10.27Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.